Literature DB >> 2343854

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries.

J V Selby1, G D Friedman, C P Quesenberry.   

Abstract

Exploratory analyses were conducted in a nested case-control study of 1,031 incident cases of essential hypertension and 1,031 persistently normotensive controls from the Kaiser Permanente Multiphasic Health Checkup cohort in Northern California. Previous analyses have confirmed hypotheses that baseline weight, subsequent weight gain, alcohol consumption, parental history of hypertension, excessive use of salt, and centralized body fat distribution are predictive of developing hypertension. In the present study, pulmonary function tests, several serum chemistries, and heart rate were strongly predictive in univariate analyses. Adjusting for the risk factors mentioned above, forced vital capacity (p less than 0.001), serum uric acid (p = 0.003), serum cholesterol (p = 0.012), and heart rate (p = 0.014) remained independently predictive. Further adjustment for baseline blood pressure completely explained the association of heart rate with hypertension, and reduced the association with serum cholesterol to borderline significance. Forced vital capacity remained a strong, inverse predictor (odds ratio, fifth vs. first quintile = 0.22, 95% confidence interval (Cl) 0.11-0.46). Uric acid remained positively related to risk (odds ratio, fifth vs. first quintile = 2.19, 95% Cl 1.20-3.98). Although neither association is presently understood, both forced vital capacity and serum uric acid are closely linked to development of hypertension and may be markers of susceptibility or intermediate steps in pathways leading to hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2343854     DOI: 10.1093/oxfordjournals.aje.a115593

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  59 in total

Review 1.  Serum uric acid as a cardiovascular risk factor for heart disease.

Authors:  M H Alderman
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  Relevance of heart rate as a risk factor in hypertension.

Authors:  P Palatini; S Julius
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

Review 4.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 5.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

6.  The relationship between serum uric acid and chronic kidney disease among Appalachian adults.

Authors:  Loretta Cain; Anoop Shankar; Alan M Ducatman; Kyle Steenland
Journal:  Nephrol Dial Transplant       Date:  2010-05-25       Impact factor: 5.992

7.  Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study.

Authors:  V Saroja Voruganti; Sandra Laston; Karin Haack; Nitesh R Mehta; Shelley A Cole; Nancy F Butte; Anthony G Comuzzie
Journal:  Am J Clin Nutr       Date:  2015-01-28       Impact factor: 7.045

Review 8.  Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?

Authors:  Mark S Segal; Elizabeth Gollub; Richard J Johnson
Journal:  Eur J Nutr       Date:  2007-09-01       Impact factor: 5.614

9.  Uric acid and insulin sensitivity and risk of incident hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  Arch Intern Med       Date:  2009-01-26

10.  Fructose and vitamin C intake do not influence risk for developing hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.